Jpmorgan Chase & CO Harmony Biosciences Holdings, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 136,806 shares of HRMY stock, worth $4.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,806

Previous 42,839 219.35%

Holding current value

$4.52 Million

Previous $1.44 Million 187.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$28.81 - $33.01 $2.71 Million - $3.1 Million	93,967 Added 219.35%	136,806 $4.13 Million
Q1 2024 May 10, 2024	SELL	$29.93 - $35.06 $2.4 Million - $2.81 Million	-80,065 Reduced 65.14%	42,839 $1.44 Million
Q4 2023 Feb 12, 2024	BUY	$19.2 - $33.78 $845,491 - $1.49 Million	44,036 Added 55.84%	122,904 $3.97 Million
Q3 2023 Nov 14, 2023	SELL	$31.89 - $39.03 $773,013 - $946,087	-24,240 Reduced 23.51%	78,868 $2.58 Million
Q2 2023 Aug 11, 2023	BUY	$30.5 - $37.4 $1.49 Million - $1.83 Million	48,914 Added 90.26%	103,108 $3.63 Million
Q1 2023 May 18, 2023	BUY	$30.8 - $53.92 $1.07 Million - $1.87 Million	34,613 Added 176.77%	54,194 $1.77 Million
Q1 2023 May 11, 2023	SELL	$30.8 - $53.92 $2.26 Million - $3.95 Million	-73,224 Reduced 78.9%	19,581 $639,000
Q4 2022 Feb 13, 2023	SELL	$45.4 - $60.91 $1.07 Million - $1.43 Million	-23,480 Reduced 20.19%	92,805 $5.11 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $812,683 - $1.07 Million	19,322 Added 19.93%	116,285 $5.15 Million
Q2 2022 Aug 11, 2022	BUY	$33.54 - $52.15 $2.4 Million - $3.73 Million	71,620 Added 282.6%	96,963 $4.73 Million
Q1 2022 May 11, 2022	BUY	$33.14 - $51.13 $99,983 - $154,259	3,017 Added 13.51%	25,343 $1.23 Million
Q4 2021 Feb 10, 2022	BUY	$34.09 - $43.91 $436,556 - $562,311	12,806 Added 134.52%	22,326 $953,000
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $244,473 - $367,567	9,520 New	9,520 $365,000

Others Institutions Holding HRMY

# of Institutions

229

Shares Held

45.1M

Call Options Held

48.2K

Put Options Held

56.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.96B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Harmony Biosciences Holdings, Inc. Transaction History